Few skincare ingredients have travelled as far, as fast, as copper peptides. Searches for them have climbed steeply, and “copper peptide serum” now appears on labels from the drugstore shelf to the luxury counter. The attention is not unearned: the molecule behind the name has more than fifty years of laboratory research behind it. But the clinical picture is thinner than the excitement suggests, and the difference matters.
This is what copper tripeptide-1 is, what the research has and has not shown, and how we think about it in Blue Osien.
Key takeaways
- “Copper peptide” in skincare usually means GHK-Cu: the small peptide GHK (glycine, histidine, lysine) bound to a copper ion. On ingredient lists it is called copper tripeptide-1 [1,2].
- GHK occurs naturally in human plasma. One review reports average levels of about 200 ng/mL at age 20, falling to about 80 ng/mL by age 60 [3].
- In laboratory studies, GHK-Cu influenced how skin cells build and remodel their surrounding matrix, including collagen and glycosaminoglycans [2,4].
- Human studies exist but are limited. A 2026 systematic review found 2 randomized controlled trials among 20 eligible studies; the rest were preclinical [5].
- Getting a hydrophilic peptide into intact skin is a real challenge, and much current research is about delivery [6,7].
What copper peptides are
GHK is a tripeptide, a chain of just three amino acids: glycine, histidine and lysine. It was first isolated from human plasma in 1973 by the biochemist Loren Pickart [2], who later showed that it forms a complex with copper(II) and helps carry the metal into cells [1]. Its affinity for copper is close to that of the copper transport site on albumin, the main protein in blood [2].
Bound to copper, the peptide becomes GHK-Cu, a deep blue complex. That color is the reason a serum built around it can look blue without any added dye. In cosmetic ingredient labeling (INCI), GHK-Cu is listed as copper tripeptide-1.
GHK is not unique to the lab. It is present in plasma, saliva and urine, and its levels decline with age [2,3]. That decline is part of why researchers became interested in it as a subject of aging research, though a falling level in the blood is not, by itself, evidence that applying the peptide to the skin replaces it.
What the laboratory research found
Most of what is known about GHK-Cu comes from cell cultures, skin models and animal studies, much of it summarized in reviews by Pickart and colleagues [2,4].
In cultured skin cells, GHK-Cu at very low concentrations has been reported to stimulate both the synthesis and the breakdown of collagen and glycosaminoglycans, and to modulate the enzymes that degrade the matrix (metalloproteinases) and their inhibitors [2]; later reviews add elastin synthesis to that list [4]. In other words, it appears to act less like an accelerator and more like a regulator of renewal, which is why researchers describe it as a tissue-remodeling molecule [4]. Gene-expression analyses have since suggested that GHK is associated with changes in the activity of a large number of human genes, many related to tissue maintenance and cellular protection [4].
These are genuine findings, published over decades. They are also findings about cells and tissue models, often at concentrations and under conditions that cannot be assumed for a cosmetic applied to the face.
What the clinical studies found
Here the evidence narrows. A 2015 review co-authored by Pickart summarizes several placebo-controlled 12-week facial studies, in groups of 41 to 71 women, that reported improvements in fine lines, wrinkles and skin density with GHK-Cu creams [2]. Independent reviewers, applying stricter criteria, count far fewer controlled trials. A 2024 review of topical GHK as an anti-wrinkle ingredient called the lack of clinical studies on GHK-Cu and its palmitoylated form “surprising”, given how widely both are used in products [7]. A 2026 systematic review of GHK-Cu in aesthetic medicine identified 20 eligible studies, of which 18 were preclinical and 2 were randomized controlled trials; the authors concluded the biological rationale is reasonable but limited by methodological variability and few well-designed trials [5].
One of those trials shows why caution is useful. In a small randomized study, people recovering from laser resurfacing used skin care with or without GHK-Cu for 12 weeks [8]. On objective measures, including blinded grading of wrinkles and skin quality, there was no significant difference between the groups. Patient satisfaction, however, was significantly higher in the GHK-Cu group [8].
Broader reviews of cosmetic peptides draw the same line. Controlled human studies report improvements in some skin measurements, but many are small, short, sponsored by industry, or test multi-ingredient formulas, which makes it hard to credit any single peptide [9].
The delivery question
GHK-Cu is hydrophilic: it dissolves readily in water, which makes crossing the outer, lipid-rich layer of the skin difficult. The studies do not all agree on how much gets through. Membrane-model studies suggested that GHK-Cu can pass the stratum corneum [2], while in a laboratory study using human skin, almost no peptide or copper passed through intact skin over nine hours; pretreating the skin with microneedles changed that dramatically [6]. Reviewers note that copper complexation and fatty-acid modification (as in palmitoyl GHK) improve permeability somewhat, and that formulation is complicated by the peptide’s water-loving and relatively unstable nature [7].
This is why delivery systems, from liposomes to microneedle patches, are such an active area of research [5,7]. It is also a reason to be skeptical of claims that copper peptides “rebuild” skin from a surface serum.
What the evidence does not yet show
The evidence does not yet show, in large, independent, well-controlled trials, how much a topical copper peptide product changes the look of aging skin on its own, or how one copper peptide product compares with another. Laboratory findings explain the interest; they do not measure a finished cosmetic. Results from one formula, at one concentration, in one study population, do not transfer automatically to a different product.
None of this makes copper peptides less interesting. It means the honest description is “a well-studied molecule with a promising biological rationale and modest clinical evidence”, not “proven to reverse aging”.
Using copper peptides thoughtfully
- Read the label for the name. On an ingredient list, look for copper tripeptide-1. The words “copper peptide” on the front of a box do not tell you how much is inside or what else is in the formula.
- Mind the company it keeps. Peptides are sensitive ingredients. In formulation research, GHK was stable in water between pH 4.5 and 7.4 but prone to breaking down under oxidative stress [2], and reviewers point to its relatively unstable nature [7]. In our own ritual, the copper peptide lives in the serum and the vitamin C derivative in the cream.
- Expect cosmetic results, described cosmetically. A well-made peptide serum can help skin look smoother and more luminous. Be wary of products that promise medical outcomes.
Why Blue Osien uses copper tripeptide-1
Blue Osien is built around a 9-peptide complex featuring copper tripeptide-1, which gives the serum its signature whisper of blue. It is paired with ectoin and a hydration matrix in a weightless, oil-free base designed to sit close to clean skin, beneath YJOR Age-Defying Face Cream. We describe what it does in cosmetic terms: smoother, more refined, more luminous-looking skin.
A note on evidence: the studies discussed here tested GHK-Cu in laboratory models or in other formulas. They are not measurements of Blue Osien, and MARSEL KEI does not publish finished-product performance figures until the finished product has been tested.
Frequently asked questions
Is copper tripeptide-1 the same as GHK-Cu? Yes. Copper tripeptide-1 is the cosmetic ingredient (INCI) name for GHK-Cu, the peptide glycyl-histidyl-lysine bound to copper.
Why are copper peptide serums blue? The copper-peptide complex itself is blue. A serum built around copper tripeptide-1 takes on that tint without added colorants.
Are copper peptides new? No. GHK was first described in the 1970s, and its copper complex has been studied for decades [1,2]. What is newer is its popularity, and research into better ways of delivering it into skin [5,7].
References
[1] Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715-717. doi:10.1038/288715a0. PMID:7453802. https://pubmed.ncbi.nlm.nih.gov/7453802/
[2] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108. PMID:26236730. https://pubmed.ncbi.nlm.nih.gov/26236730/
[3] Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. doi:10.31491/apt.2020.03.014. PMID:35083444. https://pubmed.ncbi.nlm.nih.gov/35083444/
[4] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987. PMID:29986520. https://pubmed.ncbi.nlm.nih.gov/29986520/
[5] Mokhtar J, Mohamad B, Haddad J, et al. The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthet Surg J. 2026. doi:10.1093/asj/sjag169. PMID:42619529. https://pubmed.ncbi.nlm.nih.gov/42619529/
[6] Li H, Low YSJ, Chong HP, et al. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharm Res. 2015;32(8):2678-2689. doi:10.1007/s11095-015-1652-z. PMID:25690343. https://pubmed.ncbi.nlm.nih.gov/25690343/
[7] Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts. 2024;15:30071. doi:10.34172/bi.30071. PMID:39963574. https://pubmed.ncbi.nlm.nih.gov/39963574/
[8] Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259. doi:10.1001/archfaci.8.4.252. PMID:16847171. https://pubmed.ncbi.nlm.nih.gov/16847171/
[9] Yi KH, Kim HS, Lee HE, Choi WS, Kim JH. Peptides in Aesthetic Dermatology: Classification, Fibroblast-Centered Mechanisms, Delivery Technologies, and Clinical Evidence. Life (Basel). 2026;16(10):1660. doi:10.3390/life16101660. PMID:42942246. https://pubmed.ncbi.nlm.nih.gov/42942246/